Icatibant Injection
Product Images NDC 46708-654

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 46708-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Icatibant-fig-a (Icatibant Fig A)

Icatibant-fig-a (Icatibant Fig A)
This text describes the components of a pre-filled syringe set including a plunger, protective cap for the syringe tip, capped needle with a needle cap lid, and an alcohol wipe. It clarifies that the wipe is not included in the carton.*
FDA Label Image

Icatibant-fig-b (Icatibant Fig B)

FDA Label Image

Icatibant-fig-c (Icatibant Fig C)

FDA Label Image

Icatibant-fig-d (Icatibant Fig D)

FDA Label Image

Icatibant-fig-e (Icatibant Fig E)

FDA Label Image

Icatibant-fig-f (Icatibant Fig F)

FDA Label Image

Icatibant-fig-g (Icatibant Fig G)

FDA Label Image

Tibant-fig-h (Icatibant Fig H)

FDA Label Image

Icatibant-fig-i (Icatibant Fig I)

FDA Label Image

Icatibant-fig-j (Icatibant Fig J)

FDA Label Image

Icatibant-fig-k (Icatibant Fig K)

Icatibant-fig-k (Icatibant Fig K)
This text includes angles measurements: 15 degrees, 90 degree angle, and 45 degree angle. Angle measurements are used in geometry to determine the relation between lines and shapes.*
FDA Label Image

Icatibant-fig-l (Icatibant Fig L)

FDA Label Image

Icatibant-fig-m (Icatibant Fig M)

FDA Label Image

Icatibant-fig-n (Icatibant Fig N)

FDA Label Image

Icatibant-fig-o (Icatibant Fig O)

FDA Label Image

Icatibant-graph (Icatibant Graph)

Icatibant-graph (Icatibant Graph)
This text provides information on the proportion of patients not achieving a 50% reduction in symptoms for Icatibant Injection compared to Placebo over time in hours. The sample size for Icatibant Injection is 43 and for Placebo is 45.*
FDA Label Image

Icatibant-monocarton-apl (Icatibant Monocarton Apl)

Icatibant-monocarton-apl (Icatibant Monocarton Apl)
Information about Icatibant Injection by Alembic Pharmaceuticals Limited. This product is a subcutaneous medication with a concentration of 30 mg/3 mL. It is available in single-dose pre-filled syringes. The inactive ingredients include sodium chloride, glacial acetic acid, and sodium hydroxide. It is essential to store the product between 2 to 25°C (36 to 77°F) and not freeze it. The carton should be retained until the time of administration. The syringe comes with a protective cap and one needle for administration. Full prescribing information can be obtained by contacting the toll-free number provided. This medication does not contain preservatives, and any unused portion should be discarded properly.*
FDA Label Image

Icatibant-outercarton-apl (Icatibant Outercarton Apl)

Icatibant-outercarton-apl (Icatibant Outercarton Apl)
This text appears to be a product description for an injectable medication called Icatibant Injection, containing 30 mg/3 mL (10 mg/mL). The medication is intended for subcutaneous use only and comes in single-dose prefilled syringes. The text provides information on inactive ingredients, storage instructions, administration details, and contact information for inquiries. It also emphasizes that the medication is for prescription use only and should not be frozen. Additionally, the packaging contains specific dosing and prescribing information.*
FDA Label Image

Icatibant-pfs-label-apl (Icatibant Pfs Label Apl)

Icatibant-pfs-label-apl (Icatibant Pfs Label Apl)
This is a description of Icatibant Injection in a 30mg/3 mL dosage form with each mL containing 10 mg. It is intended for subcutaneous use only and should be discarded if unused. The injection comes in a single-dose prefilled syringe. The product is manufactured by Alembic Pharmaceuticals Limited in Karakhadi, Gujarat, India. The text also includes information about the lot number and expiration date of the product.*
FDA Label Image

Icatibant-structure (Icatibant Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.